

share
Felvizumab CAS NO 167747-20-8
Unit Price:
CAS No.:167747-20-8
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Felvizumab is a monoclonal antibody specifically designed for targeted therapeutic applications. This high-purity biological agent is critical for research and development in advanced pharmaceutical formulations. It is primarily utilized by biotechnology firms and pharmaceutical manufacturers engaged in the development of novel immunotherapies and diagnostic reagents.
Application
- Pharmaceutical Research & Development: As a key biological reference standard in the discovery and validation of new therapeutic pathways.
- Immunotherapy Development: For the formulation and testing of targeted monoclonal antibody-based treatments.
- Diagnostic Reagent Production: Used in the manufacture of high-sensitivity assay kits and diagnostic tools.
- Biologics Manufacturing: Serves as an intermediate or active pharmaceutical ingredient (API) in cGMP production processes.
- Academic & Contract Research: For fundamental immunological studies and pre-clinical investigations in laboratory settings.
Basic Information
| Product Name | Felvizumab |
| CAS No. | 167747-20-8 |
| Molecular Formula | Contact for details |
| Molecular Weight | Approx. 150 kDa (Monoclonal Antibody) |
| Synonyms | Anti-Feline Immunodeficiency Virus Monoclonal Antibody; FIV mAb; Felvizumab (USAN); Monoclonal Antibody to Feline Immunodeficiency Virus; Immunoglobulin G1, anti-(feline immunodeficiency virus) (human-mouse monoclonal CL001-103 gamma1-chain), disulfide with human-mouse monoclonal CL001-103 light chain, dimer |
| EINECS | Contact for details |
Quality Control
Our Felvizumab is produced and tested under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, potency, and safety, meeting high standards for biological materials. Certificates of Analysis (COA) with detailed specifications for parameters such as purity (by HPLC), endotoxin levels, and sterility are available upon request.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. This product is hygroscopic (moisture-sensitive).
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or clear solution |
| Identification (SDS-PAGE / ELISA) | Conforms |
| Purity (HPLC-SEC) | ≥ 95% |
| Protein Content (UV Absorbance) | Contact for details |
| Endotoxin (LAL) | < 1.0 EU/mg |
| Sterility (Membrane Filtration) | Sterile |
| Biological Activity (Binding Assay) | Contact for details |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9


Pritumumab CAS NO 499212-74-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






